Evidence map›Paper›PMID 41888029›Full record

ArticleInternational journal of dermatology2026

Steroid-Modified Scabies: Quantifying a Clinically Recognized but Understudied Problem.

Attilio Di Girolamo, Mattia Cristallo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Attilio Di GirolamoDepartment of Precision and Regenerative Medicine and Ionian Area, Regional Reference Center for Allergic and Immunological Diseases, Bari, Italy.ORCID https://orcid.org/0000-0003-2416-4838
Mattia CristalloDepartment of Precision and Regenerative Medicine and Ionian Area-DiMePRe-J, Post Graduate School of Allergy and Clinical Immunology, University of Bari Aldo Moro, Bari, Italy.ORCID https://orcid.org/0009-0002-8055-5892

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corticosteroid use in undiagnosed pruritic dermatoses may modify the clinical course of scabies. Evidence indicates that steroid exposure is associated with higher mite burden, greater disease extent, and delayed healing compared with standard antiparasitic therapy alone. Prolonged steroid use may mask inflammation, delay diagnosis, and facilitate parasite persistence.

Indexed as

GlucocorticoidsPruritusScabiesAnimalsAntiparasitic AgentsDelayed DiagnosisHumansSarcoptes scabieiSeverity of Illness IndexAntiparasitic AgentsGlucocorticoidscorticosteroid exposurescabies severity scalesteroid‐modified scabies

Identifiers

PMID41888029
PMCPMC13436159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.